Daily Archives: February 15, 2017

First Wells Fargo, next Seattle’s pension fund? Activists target other investments over Dakota Access Pipeline

Fresh from their victory getting the Seattle City Council to dump Wells Fargo for lending to the Dakota Access Pipeline developers, climate activists now want to go a step further and get the city to divest employee pension funds from fossil-fuel investments.

“Wells Fargo is not enough,” City Councilmember Kshama Sawant said at a community meeting Monday night at Washington Hall, organized to discuss next steps in the fight against the Dakota Access Pipeline. “The city pension fund has $2.5 billion in fossil fuels (investments) and we are demanding that we divest from that. This is the next step. We have to strike while the iron is hot!”

Read on.

Trump Then: ‘I Would Have No Problem’ Banning Lobbyists. Trump Now: You’re Hired!



During his campaign, Donald Trump repeatedly welcomed the idea of banning lobbyists from his administration.

Fast forward eight months, and now-President Trump is welcoming them in.

Last June on CBS’s “Face the Nation,” host John Dickerson asked Donald Trump: Given the candidate’s drumbeat of criticism of the Washington lobbyist class, “Will you say ‘No lobbyists will work for me and no big donors?’”

“I would have no problem with it, honestly,” Trump responded.

After the exchange, a “Face the Nation” producer followed up with campaign spokeswoman Hope Hicks, who confirmed that, yes, Trump was referring to banning lobbyists from his administration.

The sentiment is in line with what Trump told NBC’s “Meet the Press” in another interview a year earlier, when he called banning lobbyists from working in his administration “a pretty good idea.”

As ProPublica detailed last week, a longtime construction industry lobbyist who previously worked against wage and workplace safety regulations is now in a key positionat the Department of Labor. The lobbyist, Geoff Burr, is reportedly in line to be chief of staff if Andrew Puzder is confirmed as Labor secretary.

At the Food and Drug Administration, longtime pharmaceutical lobbyist Jack Kalavritinos has a senior role in the agency’s early Trump team, according to Stat News.